| Fund Description |
| The Invesco Nasdaq Biotechnology ETF (Fund) is based on the Nasdaq Biotechnology Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The Fund and the Index are reconstituted annually in December and rebalanced quarterly in March, June, September and December. |
| Fund Profile |
| Fund Name |
Invesco Nasdaq Biotechnology ETF |
| Fund Exchange Ticker |
IBBQ |
| Fund Sponsor |
Invesco |
| Fund ISIN |
US46138G5999 |
| Net Expense Ratio |
0.00 % |
| Fund Inception Date |
11 June 2021 |
| Fund Legal Structure |
ETF (Open end fund) |
| Exchange |
NASDAQ |
| Listing Country Code |
US |
| Fund Investment Objective |
| ETF Type Specific |
US Equities - Industry Sector |
| Asset Class |
Equities (Stocks) |
| Index Linked |
Passive |
| Index Name |
NASDAQ Biotechnology Index |
| Index Provider |
Nasdaq |
| Currency Hedged |
No |
| Inverse / Leveraged |
Not Applicable |
| Developed / Emerging |
Developed Market Funds |
| Market Capitalization Range |
Broad Market / Multi-Cap |
| Growth Value |
Core / Blend |
| Continent |
North America |
| Key Statistics |
| Return As of Date |
9 August 2022 |
| Asset Under Management |
23.65 Million (USD) |
| 1 Month Total Return |
4.49 % |
| Year To Date Return |
-12.45 % |
| 1 Year Total Return |
-21.26 % |
| 3 Year Annualized Total Return |
|
| NAV |
20.7461 |
| Share Outstanding |
1,140,000 |